Moumita Dutta

About

My persistent research interests are in the field of toxicology using in vivo models and molecular biology techniques to determine the interaction between environmental factors and the pathology of host disease development. Recent emerging evidence of gut microbiome and host nuclear receptor interaction increase my attention in the field of microbiology. Training experience in UPLC-MS/MS, helped me to develop methods for metabolomics quantifications of bile acids and other essential metabolites. Use of bioinformatics in the field of toxicology and microbiology is another interest in my research. I have gathered expertise in the field of electron microscopes (TEM, SEM, confocal, fluorescence) during the time of my PhD studies. I have skills to work with animal tissues ranging from Drosophila, mice, rats to human. I have taken online course in Coursera platform to learn R statistical language. I have published 20 scientific articles in renowned toxicology journals. I have also authored approximately 20 meeting abstracts and presented my research in the regional, national, and international conferences of toxicology and advanced molecular biology. In summary, I have expertise and motivation to explore unknown fact associated between gut microbiome and host xenobiotic interactions in the development of metabolic diseases.

Employment

• University of Washington Research Scientist
  2025 - Present
• Key Proteo Inc
  2024 - 2024
• Altasciences (Canada) Scientist
  2022 - 2024
• University of Washington Research Scientist/Engineer 2
  2021 - 2022
• University of Washington Postdoc
  2019 - 2020
• University of Washington Research Scientist
  2018 - 2019

Education

• University of Burdwan PhD
  2012 - 2017
• University of Burdwan MSc
  2009 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (23)

• Editorial: Microbiome: the modulator of human health
  Frontiers in Pharmacology 2025 DOI: /10.3389/fphar.2025.1625412
  +Save
• Synergistic action of organophosphates and COVID-19 on inflammation, oxidative stress, and renin-angiotensin system can amplify the risk of cardiovascular maladies.
  Toxicology and applied pharmacology 2022 DOI: 10.1016/j.taap.2022.116267
  +Save
• Chronic exposure to ambient traffic-related air pollution (TRAP) alters gut microbial abundance and bile acid metabolism in a transgenic rat model of Alzheimer’s disease
  Toxicology Reports 2022 DOI: 10.1016/j.toxrep.2022.03.003
  +Save
• PXR and the gut-liver axis: a recent update
  Drug metabolism and disposition: the biological fate of chemicals 2021 DOI: 10.1124/dmd.121.000415
  +Save
• Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol.
  Hepatology communications 2021 DOI: 10.1002/hep4.1858
  +Save
• Neonatal exposure to BPA, BDE-99, and PCB produces persistent changes in hepatic transcriptome associated with gut dysbiosis in adult mouse livers
  Toxicological Sciences 2021 DOI: 10.1093/toxsci/kfab104
  +Save
• Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature.
  Biochemical pharmacology 2021 DOI: 10.1016/j.bcp.2021.114698
  +Save
• Understanding the physiological functions of the host xenobiotic-sensing nuclear receptors PXR and CAR on the gut microbiome using genetically modified mice
  Acta Pharmaceutica Sinica B 2021 DOI: 10.1016/j.apsb.2021.07.022
  +Save
• Immunotoxic role of Organophosphates: an unseen risk escalating SARS-CoV-2 pathogenicity.
  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2021 DOI: 10.1016/j.fct.2021.112007
  +Save
• Microbiome-encoded bile acid metabolism modulates colonic transit times
  iScience 2021 DOI: https://doi.org/10.1016/j.isci.2021.102508
  +Save